Survival Analysis on Time-To-Recovery of Diabetic Patients at Minlik Referral Hospital, Ethiopia: Retrospective Cohort Study

DOI: https://doi.org/10.21203/rs.3.rs-1015864/v1

Abstract

Aim

The study aimed to determine the time to recovery of diabetic patients who have been treated in the hospital under follow-up. 

Subject and Methods

A retrospective cohort study design was carried out. The fast blood glucose level of diabetic patients who are under follow-up in the hospital was measured from 2016 to 2020. One thousand seven hundred diabetic patients were included in the study. Kaplan-Meier, Log-rank test, global test, Schoenfeld residuals, and Cox-PH model were used for statistical analysis.

Results

Out of the total of 1278 patients, 27.4% were censored (withdrawal from follow-up) and 72.6% recovered from the diabetic disease. For sex, the expected hazard is 1.322 times higher in males than female diabetic patients or there is a 32.2% increase in the expected hazard in males relative to female diabetic patients. For Spdrt, The expected hazard is 1.164 times higher in the patients who had taken leute than diabetic patients who took doanied. For regimen, the expected hazard is 1.495 times higher in the patients who had been treated by insulin agent only than diabetic patients who were treated by oral agents only 

Conclusion

The intensive-therapy regimen, Spdrt, and gender differences were statistically significant and critically contribute to the survival time to recovery of diabetic patients. 

Introduction

Diabetes is an incurable and genealogical disease (Tarekegne et al., 2018; Berhanie, Mihretie and Anandapandian, 2019; Handayani, Nugroho and Hermawati, 2020; Fikadu et al., 2021). Chronic hyperglycemia is associated with micro-vascular and macro-vascular complications that can lead to visual impairment, blindness, kidney disease, nerve damage, amputations, heart disease, and stroke (Lea and Nicholas, 2002; Sileshi Bekele Hordofa* and Olani Debelo, 2020) .

There are three main types of diabetes: type I, type II, and gestational age. Of these, type II occurs in almost all cases (Grossman and Grossman, 2017; Ababa, Id and Id, 2019; ‘Comparative Study Of Some Immunological Aspects Between Type I And Type II Diabetic Mellitus In Iraqi Patients Of Thi-Qar’, 2020). Income(Rabi et al., 2006), education(Whitaker et al., 2014), age(Selvin and Parrinello, 2013), gender(Siddiqui, Khan and Carline, 2013), past medical history(Tattersall, 2010), family history(Ard, Tettey and Feresu, 2020), health complication(Abejew, Belay and Kerie, 2015), types of medication(Stubbs, Levy and Dhatariya, 2017) and Spdrt(Lv and Guo, 2020) are associated with diabetes. With age, the body's sugar level may drop, and the disease can be fatal. The internal structure of the body can be the cause of the disease, and there is a difference between men and women (Negash Terefe, Abiyot, 2017).

Diabetes is directly related to high blood pressure so that it is important to measure and treat the blood pressure (Grossman and Messerli, 2011; Muleta et al., 2017; Akalu and Belsti, 2020).

Materials And Methods

Study design, setting and Sample size

The study was conducted at Minlik Referral Hospital, Ethiopia, found in the capital city of Ethiopia, Addis Ababa. The data was measured by the blood glucose level of diabetic patients at the hospital, covering the period from 2009 to 2016, and 1278 patients were eligible for the study. 

Data collection, procedure and quality control

 Data collectors also participated in the hospital's staff and experts in the field. The data has been monitored and verified by experts based on the questionnaire checklist developed by the researchers. Data were categorized, compiled, coded, and checked for completeness, accuracy. 

Data processing and analysis

The data were entered into SPSS (version 20) and exported to R-software (version 4.06) for analysis. Descriptive statistics have been applied to analyze patient characteristics such as mean, variance, median, percentile, and proportions of two groups (Kaplan-Meir). A survival model such as the Cox-proportional model was used to assess the hazard effect of seemingly significant predictors of the outcome variable. The p-value <0.05 was considered statistically significant. 

Variables of Study 

The dependent variable would be divided into two categories: Time to recovery of diabetic patients is an event while withdrawal from follow-up from different reasons and death are considered as censored. When the variable is properly measured, it serves as a key pillar for data analysis and discussion, as well as conclusions.  The following are the main factors that affect the outcome variable: Sex of Patients, Types of Diabetes, Age of Patients, Past Medical History, Family History, Complication, Marital Status, Employee Status, Spdrt, SBP, DBP, Weight, and Time..   

Operational definitions 

Diabetic mellitus: primarily characterized by high blood glucose levels (hyperglycemia), polydipsia, and polyphagia(Alam et al., 2021).

Type II diabetic miletus: Type 2 diabetes mellitus (DM) is a chronic metabolic disorder in which prevalence has been increasing steadily all over the world (Olokoba, Obateru and Olokoba, 2015).

Type I diabetic mellitus:  It often starts in childhood. However, it can start in adulthood (Johns Hopkins University and Johns Hopkins Health System, 2011).

 Hypertension: Hypertension is defined as a systolic blood pressure of 140 mm Hg or greater and/or a diastolic pressure of 90 mm Hg or greater in subjects who are not taking antihypertensive medication (Pardi et al., 2009).

Results

Out of the total of 1278 participants, 27.4% were censored (withdrawal from follow-up, death), and 72.6% recovered from the diabetic disease (Table 1). 

Table 1: Status of Diabetic   Patients

Status

        Frequency

              Percent

Censored

        350

                27.4

Event

        928

                72.6 

Total

       1278

               100.0

The overall mean and median estimated survival time of diabetic patients under the follow-up study respectively was 50.48 and 32 (Table 2).

Table 2: Time to recovery in weeks

Status 

Mean 

Median 

Std.deviation 

Min 

Max 

Time 

50.48

32

52.52

0

318

 Table 2 also presents the minimum and maximum follow-up per week were respectively 0 and 318.   15.6% of female patients and 11.7 % of male patients lost follow-up.

 33.3% of male and 39.4% female patients recovered from diabetic disease. Generally, female patients had more time to recover from the diabetic disease (Table 2, Figure 1).

 Age of the patients with intervals 15 to 29,30 to 44, 45 to 59,60 to 74, and  more than 74   were  3.8 %,6%,9.9% ,7.3%  and 0.5 % respectively  censored, and   10.8 %,15.2%,25.2%,20% and 1.5 % of patients were recovered from the disease(Table 3, Figure 2). 

5.9 % of Type I DM   and 21.4 % of Type II DM patients were censored whereas 16.4 % and 56.2 % of patients with Type I and Type II had been recovered from the diabetic disease. Generally, patients with type II had more recovered from the disease (Table 2, Figure 3).

Table 3: Baseline  patient’s characteristics

Variable

Category

Patient status 

 

Censored

Event

Sex

Male

150(11.7)

424(33.3)

Female

200(15.6)

504(39.4)

Types of  DM

Type I

76(5.9)

210(16.4)

Type II

274(21.4)

718(56.2)

Past medical history

yes

96(7.5)

267(20.9)

No

254(19.4)

661(51.7)

Family history

Yes

64(5)

182(14.2)

No

286(22.4)

746(58.4)

Is there complication

Yes

235(18.4)

621(48.6)

No

115(9)

307(24)

Marital status

Married

217(17)

573(44.8)

Single

133(10.4)

355(27.8)

Educational status

Educated

265(20.7)

705(55.2)

Uneducated

85(27.4)

223(72.6)

Employee status

Employee

171(13.4)

463(36.2)

Unemployed

179(14)

465(36.4)

7.2 %, 15.8 %, 4.4% of patients respectively took oral agents only, insulin agents only, and insulin and oral agents were censored whereas 15.6%,45.9 %, and 11% patients respectively who had taken oral agents only, insulin agents and insulin and oral agents only recovered from the disease( Table 3, Figure 7).  

Patients who had taken the specific types of drugs at Time such as doanied, HCT, metformin,monotend,leute,regular and all orals respectively were 0.3%,0.7%,0.6%,15.3%,0.8%,1.1%,and 1.6%  censored, and 17.5%,1.6%,1.6%,45%2%,1.9% and 3.1 % were recovered from the disease (Table 3,Figure 8). 

Patients with systolic blood pressure below, normal and high were 5.2%,8.7%, and 13.5% respectively censored, and 13.5%,22.5%, and 36.6% of patients with systolic blood pressure respectively were recovered from the disease(Table 3, Figure 10). 

Table 4: Baseline Descriptive statistics of patient’s characteristics

 Variable

Category

Patient status in%

 

Censored

Event

Regimen 

Oral agents only 

92(7.2)

200(15.6)

Insulin agents only 

202(15.8)

587(45.9)

Insulin and oral agents 

56(4.4)

141(11)

Spdrt

Doanied

93(.3)

224(17.5)

HCT

9(0.7)

20(1.6)

Metformin 

8(0.6)

20(1.6)

Monotend 

196(15.3)

575(45)

Leute

10(0.8)

25(2)

Regular 

14(1.1)

24(1.9)

All orals 

20(1.6)

40(3.1)

SBP

<=110(below)

66(5.2)

173(13.5)

110-130(normal)

111(8.7)

287(22.5)

>=130(high)

173(13.5)

468(36.6)

DBP 

<=60(below)

7(0.5)

15(1.2)

60-80(normal)

134(10.5)

348(27.2)

>=80(high)

350(27.4)

928(72.6)

Age category 

15-29

48(3.8)

138(10.8)

30-44

77(6)

194(15.2)

45-59

126(9.9)

322(25.2)

60-74

93(7.3)

255(20)

>74

6(0.5)

19(1.5)

Patients with diastolic pressure below, normal and high were 0.5%,10.5%, and 27.4% respectively censored, and 1.2%,27.2%, and 72.6% of patients with systolic blood pressure respectively were recovered from the disease(Table 3, Figure 9). 

7.5% of patients who had a past medical history and 19.4% of patients who had no past medical history lost to follow-up. 20.9% of patients who had past medical history recovered from the disease, and 51.7% of patients who had no past medical history had recovered from diabetic disease (Table 2, Figure 4).

5% of Patients that family history and 22.4% of patients whose family history was censored. 14.2 % of patients whose family history recovered from the disease, and 58.4% of patients who had family history recovered from the disease (Table 2, Figure 5). 

Discussion

The diabetic disease or diabetes is not curable. The cause of the disease is high blood sugar in the blood. However, it is possible to treat through medication and traditional methods. The aim of the study focused on determining the time to recurrence of diabetic patients over the entire follow-up period at Minlik Referral Hospital, Ethiopia, found in Addis Ababa, headquarter of Ethiopia. The retrospective cohort study was conducted. The data were analyzed by R-software (version 4.05).

Among the total of 1278, 72.6% of diabetic patients experienced to time to recovery of diabetic patients and 27.4% loss to follow up from study. The mean and median of time to recurrence of diabetic patients respectively are 50.48 and 32.

Figures (1-10) present the Kaplan–Meier survival functions of categorical variables among diabetic Patients under follow-up at Tepi General Referral Hospital, Ethiopia, found in the capital city of Ethiopia, from 2009 to 2016. The plot shows that the estimated survival function curve for female diabetic patients is above that of male diabetic patients over the entire follow-up period, giving evidence for a higher probability of survival and lower risk of recovery for females as compared with males. It indicated that female patients have better recovery time than male diabetic patients (Figure 1). Thus, females are more prevalent in this study, which is consistent with the study done in a hospital-based cross-sectional study at Harar and Dire Dawa (Ayele, Mengesha and Tesfa, 2019) .

The estimated survival function curve for patients with Type II DM is above that of diabetic patients with type I DM over the entire follow-up period, giving evidence for the higher probability of survival and lower risk of recovery for patients with type II DM as compared with patients with type IDM. It   indicated that patients with type II DM have better recovery time than diabetic patients with type I DM, which is consistent with the study in Palestinian(Salameh et al., 2019), Gurage Zone(Migora et al., 2021), Amhara region(Getie et al., 2021),Rwanda (Bavuma et al., 2020).

Patients with high systolic blood pressure (SBP) are high percentage to time-to-recover of diabetic patients as compared to patients with below and normal systolic blood pressure and similar results from patients with high diastolic blood pressure (Muleta et al., 2017).

Table 5: Log-rank test for the categorical variables

Variables
Chi-square
df
P-value
Sex
20
1
0.0198
Age category
2.9
4
0.6
Family history
1
1
0.3
Marital status
0.2
1
0.7
Educational status
0
1
0.9
Employ status
0.1
1
0.8
Regime
16
2
0.0549
Spdrty
10.1
6
0.1
SBP
0.1
2
0.9
DBP
0.2
2
0.9
Complication
0.1
1
0.8

Table 5 presented us for comparing the group of categorical variables revealed that the survival time of male and female to diabetic disease is different (chi-squared value=20, df=1,p-value=0.0198.It is statistically significant) (Table 5). All factors except sex are not statistically significant. Thus, there are no more differences between groups on survival time of diabetic patients (Table 5, Figures (2-10)).

Table 6: Global test for Assumption of Cox proportional model

Variables 
Chi-square
df
p-value 
Sex
1.4407
1
0.230
Age categories 
5.780
4
0.216
Types of DM
0.9823
1
0.322
Past Medical History 
0.1309
1
0.718
Family history 
0.0169
1
0.897
Complication 
1.6431
1
0.200
Marital status 
1.1073
1
0.293
Educational Status 
0.9911
1
0.319
Employee 
1.1297
1
0.288
Regime 
0.6300
2
0.730
Spdrty
9.4169
6
0.151
SBP
3.1085
2
0.211
DBP
3.4618
2
0.177
Wight
0.9052
1
0.341
GLOBAL-test 
37.3800
25
0.053

It is the fact that the violation of proportionality of hazard is the critical problem of assumption of Cox proportional hazard analysis. Thus, checking the assumption of the model and its validity is a must. The assumption of the Cox proportional hazard model can be checked by global test and graphical techniques (Schoenfeld residuals). The chi-square =37.38 with the degree of freedom 25 and p-Value=0.053 is statistically insignificant. Thus, the assumption of the Cox proportional model is met (Table 6). 

Figures (11-13) presented Schoenfeld residuals for the categorical variables to show whether the assumption of the Cox proportional hazard model is violated or not. 

The graphs for all categorical variables are fairly flat; the assumption of proportionality is not (much) violated (Figures 11, 12, 13). Thus, the global test and Schoenfeld residuals showed the assumption of the Cox proportional model is met.

Non-linearity assumption is not the problem for categorical variables, however, non-linearity assumption is a problem of continuous variables. Plotting martingale residuals is to detect the non-linearity assumption of the Cox proportional hazard model. Thus, there is no specific pattern for the dependent variable versus the weight of patients, therefore the assumption of the model is not violated (Figure 14).   

Table 7: Multivariable Cox-PH model for diabetic patients 

Variables                            
 Category 
 
Coef
HR
Se(coef)
z
p-value
Sex(ref=female)
Male
 
0.279  
1.322  
0.074  
3.777
0.0001
 
Age(ref=15-29)
30-44
 
-0.128 
0.880  
0.142
-0.898
0.3689
45-59
 
0.067 
1.069  
0.180  
0.374
0.7085
60-74
 
0.172  
1.188  
0.185 
0.929
0.8453
>74
 
0.005  
1.005  
0.298  
0.015
0.9879
TypeDM(ref=type I)
Type II
 
-0.014
0.986  
0.133
-0.104
0.9173
PMedh(ref=yes)
No
 
0.021 
1.021  
0.086  
0.246
0.8054
FamH(ref=yes)
No
 
-0.072  
0.931  
0.098
-0.735
0.4624
Comp(ref=yes)
No
 
0.004 
1.004  
0.079  
0.056
0.9551
Marst(ref=marrid)
Single
 
0.025  
1.026  
0.075  
0.340
0.7339
Educst(ref=educated)
uneducated
 
0.037  
1.038  
0.096  
0.390
0.6966
Empst(ref=employe)
Unemployed
 
-0.042 
0.959  
0.084
-0.496
0.6202
Regimen(ref=oral)
Insulin  
 
0.402 
1.495 
0.193  
2.085
0.0370
Insul and oral 
 
-0.016 
0.984  
0.116
-0.136
0.8914
 
 
Spdrt(ref= Doanied)
HCT
 
-0.012 
0.988 
0.248
-0.049
0.9606
Metformin 
 
-0.080 
0.923  
0.239
-0.336
0.7371
Monotend 
 
-0.131  
0.877  
0.188
-0.697
0.4859
Leute
 
0.152 
1.164 
0.235 
0.647
0.0178
Regular 
 
-0.182 
0.834  
0.235
-0.773
0.4393
All
 
-0.031  
0.969  
0.178
-0.175
0.8614
SBP(ref=below)
Normal
 
-0.049 
0.951  
0.109
-0.457
0.6474
high
 
-0.072  
0.931
0.1201
-0.597
0.5503
DBP(ref=below)
Normal
 
0.192  
1.213  
0.279 
0.686
0.4929
 
high
 
0.257  
1.293 
0.283  
0.907
0.3641
Weight
continuous
 
0.002  
1.002  
0.003  
0.667
0.5049

Likelihood ratio test=44.77 on 25  df, p=0.008892, n= 1278, number of events= 928

Sex, regimen, and Sport are significant factors associated time to Recurrence of diabetic Patients whereas age group (30-44, 45-59, 60-74,>74), past medical history, family history, health complication, education status, marital status, SBP and DBP and types of diabetic Mellitus at baseline are not significant effect for time to recurrence of diabetic patients, hence these variables are not included in multivariable analysis (Table 7). Considered Cox-PH model ) and the result of multivariable analysis, the fitted model can be: )

For interpretability, the hazard ratio for the parameter estimates estimated. For sex,   The expected hazard is 1.322 times higher in male than female diabetic patients or there is a 32.2% increase in the expected hazard in males relative to female diabetic patients holding other variables are constant, which is consistent with the study done   (Hanefeld et al., 1996; Icks et al., 2012; Whitaker et al., 2014; Muleta et al., 2017; Tachkov et al., 2020).

For Spdrt, exp(0.152) = 1.164. The expected hazard is 1.164 times higher in the patients who had taken leute than diabetic patients who took doanied. Or, there is a 16.4% increase in the expected hazard in the patients who took leute relative to diabetic patients those who had taken doanied holding other variables constant.

For regimen, exp(0.402) = 1.495. the expected hazard is 1.495 times higher in the patients who had been treated by insulin agent only than diabetic patients who were treated by oral agents only. Or, patients who had been treated by insulin agents only is 49.5% increase as compared to diabetic patients those who treated by oral only holding other variables constant, which is consistent with the study done in  American Diabetes Association (Care and Suppl, 2019).

Conclusion

Diabetes is an incurable and genealogical disease. The cause of Diabetes is defects in insulin imbalances. It can cause health complications to death, but it can be possible to control and minimize the risk of the complication through medication. Hence, the objective of the study aimed to determine the time-to-recovery of diabetic patients and associated factors on the entire follow-up period at Tepi General Hospital. 

From statistical results, among medication of regimen, 45.9% of patients who had taken insulin agents are recovered from the disease while 15.8% of patients had interrupted their follow up from study. Under Kaplan-Meier survival curves and Log-rank test, the survival times of patients among gender groups are different, hence females are more likely to survive as compared to males. The assumption of the Cox-PH model has been checked by Schoenfeld residuals and GLOBAL-test and the assumption of the model is not violated. In the multivariable Cox-PH model, sex being male; regimen being insulin agents only and Sport being leute are statistically significant. Thus, gender being male is a high risk than female, regimen being insulting agents is high risk and Sport being Leute is high risk for time to recovery of diabetic patients.  

Abbreviations

Cox-PH-Cox proportional hazard ; DM-Diabetic Mellitus ; KM-Kaplan-Meier;Sport-Specific drug at the time; BP-systolic blood pressure; BP-diastolic blood pressure 

Declarations

Acknowledgment 

All authors acknowledge those who intensively contributed to the study.

Funding 

Not applicable

Availability Data and materials 

The data will be given upon request on behalf of the corresponding author 

Declarations 

Ethical approval and Consent to participate 

The institutional review board of the hospital approved Ethical clearance.  The informed consent was obtained from the hospital manager for representing the patients' profiles seated in the hospital. The data obtained from the hospital were kept confidentially and put the questionnaire in a safe place

Consent for publication

Not applicable

Conflict of interest 

The authors do not have any conflict of interest.

Authors’ contributions 

All authors conducted the research, and write in the manuscript.

References

Ababa, A., Id, T. W. L. and Id, B. T. A. (2019) ‘Time to optimal glycaemic control and prognostic factors among type 2 diabetes mellitus patients in public teaching hospitals’, PLoS ONE, pp. 1–12.

Abejew, A. A., Belay, A. Z. and Kerie, M. W. (2015) ‘Diabetic Complications among Adult Diabetic Patients of a Tertiary Hospital in Northeast Ethiopia’, Advances in Public Health, 2015, pp. 1–7. doi: 10.1155/2015/290920.

Akalu, Y. and Belsti, Y. (2020) ‘Hypertension and its associated factors among type 2 diabetes mellitus patients at Debre Tabor general hospital, northwest Ethiopia’, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, pp. 1621–1631. doi: 10.2147/DMSO.S254537.

Alam, S. et al. (2021) ‘Diabetes Mellitus: Insights from Epidemiology, Biochemistry, Risk Factors, Diagnosis, Complications and Comprehensive Management’, Diabetology, 2(2), pp. 36–50. doi: 10.3390/diabetology2020004.

Ard, D., Tettey, N.-S. and Feresu, S. (2020) ‘The Influence of Family History of Type 2 Diabetes Mellitus on Positive Health Behavior Changes among African Americans’, International Journal of Chronic Diseases, 2020, pp. 1–8. doi: 10.1155/2020/8016542.

Ayele, B. H., Mengesha, M. M. and Tesfa, T. (2019) ‘Predictors of self-care activities of outpatient diabetic residents in Harar and Dire Dawa: A hospital-based cross-sectional study’, SAGE Open Medicine, 7(1–10), p. 205031211986564. doi: 10.1177/2050312119865646.

Bavuma, C. M. et al. (2020) ‘Socio-demographic and clinical characteristics of diabetes mellitus in rural Rwanda : time to contextualize the interventions ? A cross-sectional study’, BMC Endocrine Disorders. BMC Endocrine Disorders, 20(180), pp. 1–10.

Berhanie, H., Mihretie, Z. and Anandapandian, K. T. K. (2019) ‘Association between socio-demographic factors and blood groups with risk of diabetes mellitus in Dangila hospital , Awi Zone , North West Ethiopia’, Indian Journal of Medical Sciences, 71(2), pp. 82–87. doi: 10.25259/IJMS.

Care, D. and Suppl, S. S. (2019) ‘15. Diabetes care in the hospital: Standards of medical care in diabetesd2019’, Diabetes Care, 42(January), pp. S173–S181. doi: 10.2337/dc19-S015.

‘Comparative Study Of Some Immunological Aspects Between Type I And Type II Diabetic Mellitus In Iraqi Patients Of Thi-Qar’ (2020), 07(01), pp. 3537–3546.

Fikadu, T. et al. (2021) ‘Determinants of peripheral neuropathy among diabetic patients under follow-up in chronic care clinics of public hospitals at’, PLoS ONE, 88, pp. 1–13. doi: 10.1371/journal.pone.0246722.

Getie, A. et al. (2021) ‘Determinants of diabetes ketoacidosis among diabetes mellitus patients at North Wollo and Waghimra zone public hospitals, Amhara region, Northern Ethiopia’, BMC Endocrine Disorders. BMC Endocrine Disorders, 21(1), pp. 1–9. doi: 10.1186/s12902-021-00692-y.

Grossman, A. and Grossman, E. (2017) ‘Blood pressure control in type 2 diabetic patients’, Cardiovascular Diabetology. BioMed Central, 16(1), pp. 1–15. doi: 10.1186/s12933-016-0485-3.

Grossman, E. and Messerli, F. H. (2011) ‘Management of blood pressure in patients with diabetes’, American Journal of Hypertension. Nature Publishing Group, 24(8), pp. 863–875. doi: 10.1038/ajh.2011.77.

Handayani, O. W. K., Nugroho, E. and Hermawati, B. (2020) ‘Determinant of Diabetes Mellitus Focusing on Differences of Indonesian Culture : Case Studies in the Java and Outer Java Region in Indonesia Abstract ’:, The Open Public Health Journal, pp. 323–330. doi: 10.2174/1874944502013010323.

Hanefeld, M. et al. (1996) ‘Risk factors for myocardial infarction and death in newly detected NIDDM: The Diabetes Intervention Study, 11-year follow-up’, Diabetologia, 39(12), pp. 1577–1583. doi: 10.1007/s001250050617.

Icks, A. et al. (2012) ‘Time-dependent impact of diabetes on mortality in patients with stroke: Survival up to 5 years in a health insurance population cohort in Germany’, Diabetes Care, 35(9), pp. 1868–1875. doi: 10.2337/dc11-2159.

Johns Hopkins University and Johns Hopkins Health System (2011) ‘Health Information from the Experts at Johns Hopkins Medicine’, Health Information from experts as Johns Hokpins Medicine.

Lea, J. P. and Nicholas, S. B. (2002) ‘Diabetes mellitus and hypertension: key risk factors for kidney disease.’, Journal of the National Medical Association, 94(8 Suppl).

Lv, Z. and Guo, Y. (2020) ‘Metformin and Its Benefits for Various Diseases’, Frontiers in Endocrinology, 11(April), pp. 1–10. doi: 10.3389/fendo.2020.00191.

Migora, B. et al. (2021) ‘Survival time to development of hypertension and its predictors among a cohort of diabetic patients in health facilities of gurage zone: A retrospective follow-up study’, Vascular Health and Risk Management, 17(May), pp. 259–266. doi: 10.2147/VHRM.S297968.

Muleta, S. et al. (2017) ‘Blood pressure control and its determinants among diabetes mellitus co-morbid hypertensive patients at Jimma University medical center, South West Ethiopia’, Clinical Hypertension. Clinical Hypertension, 23(1), pp. 1–9. doi: 10.1186/s40885-017-0085-x.

Negash Terefe, Abiyot, A. B. G. (2017) ‘Modeling Time-to- Recovery of Adult Diabetic Patients Using Cox-Proportional Hazards Model’, International Journal of Statistical Distributions and Applications, 3(4), p. 67. doi: 10.11648/j.ijsd.20170304.12.

Olokoba, A. B., Obateru, O. A. and Olokoba, L. B. (2015) ‘Type 2 Diabetes: a Review of Current Trends -’, Journal of clinical medicine, 7(18), pp. 61–66.

Pardi, D. S. et al. (2009) ‘Clinical guidelines for the management of pouchitis’, Inflammatory Bowel Diseases, 15(9), pp. 1424–1431. doi: 10.1002/ibd.21039.

Rabi, D. M. et al. (2006) ‘Association of socio-economic status with diabetes prevalence and utilization of diabetes care services’, BMC Health Services Research, 6, pp. 1–7. doi: 10.1186/1472-6963-6-124.

Salameh, B. et al. (2019) ‘Clinical and socio-demographic parameters contributing to treatment incompliance in Palestinian patients with diabetes’, Therapeutic Advances in Endocrinology and Metabolism, 10, pp. 1–13. doi: 10.1177/2042018819825542.

Selvin, E. and Parrinello, C. M. (2013) ‘Age-related differences in glycaemic control in diabetes’, Diabetologia, 56(12), pp. 2549–2551. doi: 10.1007/s00125-013-3078-7.

Siddiqui, M., Khan, M. and Carline, T. (2013) ‘Gender Differences in Living with Diabetes Mellitus’, Materia Socio Medica, 25(2), p. 140. doi: 10.5455/msm.2013.25.140-142.

Sileshi Bekele Hordofa* and Olani Debelo (2020) ‘Statistical analaysis of the Survival of Patients with Diabetes Mellitus : A Case Study at Nekemte Hospital ’, American Journal of Biometrics & Biostatistics Research, 4(1), pp. 1–7.

Stubbs, D. J., Levy, N. and Dhatariya, K. (2017) ‘Diabetes medication pharmacology’, BJA Education. British Journal of Anaesthesia. Published by Elsevier Ltd., 17(6), pp. 198–207. doi: 10.1093/bjaed/mkw075.

Tachkov, K. et al. (2020) ‘Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria’, PLoS ONE, 15(5), pp. 1–16. doi: 10.1371/journal.pone.0232815.

Tarekegne, F. E. et al. (2018) ‘Sociodemographic and behavioral characteristics associated with self- reported diagnosed diabetes mellitus in adults aged 50 + years in Ghana and South Africa : results from the WHO- SAGE wave 1’, BMJ Open Diabetes Research &Care, pp. 1–11. doi: 10.1136/bmjdrc-2017-000449.

Tattersall, R. B. (2010) The History of Diabetes Mellitus, Textbook of Diabetes: Fourth Edition. doi: 10.1002/9781444324808.ch1.

Whitaker, S. M. et al. (2014) ‘The Association Between Educational Attainment and Diabetes Among Men in the United States’, American Journal of Men’s Health, 8(4), pp. 349–356. doi: 10.1177/1557988313520034.